Australian Clinical Labs Ltd (AU:ACL) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Australian Clinical Labs Limited has announced the extension and amendment of their CEO and Managing Director, Ms. Melinda McGrath’s contract, now set to end on August 30, 2026. McGrath’s new contract includes a fixed annual remuneration of $1.5 million, performance-based variable pay, and eligibility for long-term cash incentives up to $2 million, further entrenching her leadership role within the company.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue